Central Diabetes Insipidus
📧 Sign up to get email alerts when something new happens for Central Diabetes Insipidus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-27FDA Approved: DESMOPRESSIN ACETATE — Original Application (Caplin Steriles Limited)
FDA approved Desmopressin Acetate from Caplin Steriles Limited under an Original Application (ANDA). This marks the approval of a generic De…
-
FDA approval · 2026-02-25FDA Approved: DESMODA — Original Application (Eton Pharmaceuticals, Inc.)
FDA approves DESMODA (desmopressin acetate oral solution) under an original NDA from Eton Pharmaceuticals; the product provides a new oral f…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
This clinical trial investigates copeptin levels as a biomarker for postoperative central diabetes insipidus in pediatric patients after neu…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) [Phase 4]
Phase 4 clinical trial investigating an oxytocin-deficient state and its clinical relevance in pituitary/hypothalamic disorders; the study s…
-
CLINICAL_TRIALS other · 2026-01-05Clinical Trial Update: Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus [Phase 2]
Phase 2 clinical trial evaluating oxytocin substitution therapy for central diabetes insipidus; currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study) [NA]
A completed clinical trial evaluating mannitol-induced copeptin release in healthy individuals and people with polyuria-polydipsia syndrome/…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls [Phase 2]
Phase 2 clinical trial investigating intranasal oxytocin to improve sexual well-being in patients with arginine vasopressin deficiency and h…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency [Phase 1]
Phase 1 clinical trial evaluating the safety and tolerability of intranasal oxytocin in patients with arginine-vasopressin deficiency, i.e.,…
-
FDA approval · 2025-08-27FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Avenacy, Inc.)
FDA approved a supplemental application for Desmopressin Acetate by Avenacy, Inc.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls [Phase 2]
Phase 2 clinical trial investigating intranasal oxytocin for emotion recognition and stress-induced cortisol response in central diabetes in…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls [NA]
Clinical trial update studying plasma oxytocin changes in response to low-dose MDMA versus placebo in patients with central diabetes insipid…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children [NA]
A pediatric trial evaluating arginine-stimulated copeptin for diagnosing polyuria-polydipsia syndrome, including primary polydipsia and cent…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) [Phase 4]
Phase 4 clinical trial investigating identification and clinical relevance of an oxytocin-deficient state in patients with hypopituitarism a…
-
FDA approval · 2024-03-21FDA Approved: DESMOPRESSIN ACETATE — Original Application (Aurobindo Pharma Limited)
FDA approved desmopressin acetate from Aurobindo Pharma Limited under an original abbreviated new drug application (ANDA213095).
-
FDA approval · 2024-02-09FDA Approved: VASOPRESSIN — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for a generic vasopressin product from Sagent Pharmaceuticals.
-
FDA approval · 2023-03-20FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sun Pharmaceutical Industries Limited)
FDA approved a generic version of Desmopressin Acetate from Sun Pharmaceutical Industries Limited under an original ANDA.
-
FDA approval · 2022-11-16FDA Approved: DESMOPRESSIN ACETATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the Original Application for Desmopressin Acetate from Fresenius Kabi USA, LLC (ANDA216922). This marks the approval of a gener…
-
FDA approval · 2022-08-19FDA Approved: DESMOPRESSIN ACETATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Desmopressin Acetate from Dr. Reddy's Laboratories Inc. via an Original Application for a generic product.
-
FDA approval · 2022-08-15FDA Approved: VASOPRESSIN — Original Application (Eugia US LLC)
FDA approved the original application for VASOPRESSIN from Eugia US LLC, a generic vasopressin product. It is indicated for use as a vasopre…
-
FDA approval · 2020-02-14FDA Approved: DESMOPRESSIN ACETATE — Original Application (Dr.Reddys' Laboratories Inc)
FDA approved an original application for Desmopressin Acetate from Dr. Reddy's Laboratories Ltd., a generic version of desmopressin acetate.
-
FDA approval · 2019-10-24FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for Desmopressin Acetate, enabling the generic version to be marketed.
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Desmopressin acetate by Meitheal Pharmaceuticals, resulting in a label update associated with th…
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Desmopressin Acetate from Sagent Pharmaceuticals, resulting in changes to the product labeling.
-
FDA approval · 2019-01-28FDA Approved: DESMOPRESSIN ACETATE — Original Application (KVK-TECH, INC.)
The FDA approved Desmopressin Acetate from KVK-Tech under an Original Application, providing a new generic option for this drug product.
-
FDA approval · 2017-08-22FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)
FDA approved the Original Application for Desmopressin Acetate (DESMOPRESSIN ACETATE) by Sagent Pharmaceuticals, providing a generic version…